Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma

The involvement of the KYN pathway enzymes and catabolites in ccRCC occurs via both immune and nonimmune mechanisms. Our data suggest that KTR could serve as a marker of ccRCC aggressiveness and as a prognostic factor for CSS and PFS.